|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.04.26 - 13:21
|
Baxter Reports First-Quarter 2026 Results (Business Wire)
|
|
|
Sales from continuing operations of $2.7 billion increased 3% on a reported basis and declined 1% on an organic basis1,2
U.S. GAAP3 diluted earnings per share (EPS) (loss) from continuing operations of ($0.03); adjusted diluted EPS from continuing operations of $0.36
Reiterates full-year 2026 financial outlook
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global medtech leader, today reported results for the first quarter of 2026.
“Financial results for the quarter overall were in line with our expectations, and we are making progress to stabilize the business, embed a culture of continuous improvement, and strengthen execution,” said Andrew Hider, president and CEO. “Although more work remains to achieve our full potential, Baxter continues to take the decisive steps necessary to fulfill our commitment to delivering better and more consistent results for our shareholders. I want to thank our colleagues for their resilience, dedication and mission-driven focus to support...
|
|
|
|
|
|
|
|
|
|
|
08.04.26 - 22:18
|
Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors (Business Wire)
|
|
|
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medtech company, will host a conference call to discuss its first-quarter 2026 financial results on Thursday, April 30, 2026 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I946023356 to pre-register for the call and receive the call information.
This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission.
About Baxter
At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched portfolio of c...
|
|
|
08.04.26 - 12:54
|
Kontoor Brands Announces Expanded Global Leadership Role for Joseph Alkire (Business Wire)
|
|
|
GREENSBORO, N.C.--(BUSINESS WIRE)--$KTB--Kontoor Brands, Inc. (NYSE: KTB), today announced that Joseph Alkire will assume an expanded role on Kontoor's Executive Leadership Team, effective immediately. In addition to his responsibilities as Chief Financial Officer and Global Head of Operations, Alkire will assume global responsibilities for the Helly Hansen brand.
“Joe has been my strategic partner since the early stages of the acquisition, leveraging our collective experience in the outdoor category to shape the role Helly Hansen will play in Kontoor's next phase of growth," said Scott Baxter, President, Chief Executive Officer and Chairman of the Board of Directors. "There is no one better positioned to guide the Helly Hansen brand forward as we focus on creating broad-based momentum, positioning the brand to deliver strong revenue and profit growth over time.”
“Under Børre Hegbom's leadership as SVP and Global Head of Helly Hansen, the team has built tremendous momentum,” said Jos...
|
|
|
|
|
30.03.26 - 22:06
|
Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth (Business Wire)
|
|
|
Jason Richardson Named Chief Financial Officer, Succeeding Michael Bourque
Dominic Hulton Named Chief Marketing Officer
Corey Moritz Appointed Vice President, U.S. Business to Business SalesBEVERLY, Mass.--(BUSINESS WIRE)--$INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the following leadership appointments designed to accelerate the company's next phase of growth.
Jason Richardson Appointed Chief Financial Officer
Jason Richardson has been appointed Chief Financial Officer, effective April 6, 2026. Mr. Richardson succeeds Michael Bourque, who will step down from his role as Chief Financial Officer on that date. Mr. Bourque will serve in an advisory capacity until June 30, 2026, to ensure a smooth transition.
Mr. Richardson joins Inogen from Baxter International Inc., where he most recently served as Chief Financial Officer and Vice President of the Healthcare Systems & Technologies...
|
|
|
25.03.26 - 21:36
|
Baxter to Host Annual Meeting of Stockholders in Virtual Format (Business Wire)
|
|
|
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2026 Annual Meeting) in a virtual format on Tuesday, May 5, 2026 at 9 a.m., Central Time, as disclosed in Baxter's proxy statement for the 2026 Annual Meeting. Online access to the 2026 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2026 Annual Meeting in person. The virtual format provides a safe, convenient and cost-effective experience to all stockholders and employees, regardless of location.
Anyone who would like to attend the virtual 2026 Annual Meeting is encouraged to access the meeting in advance of the designated start time. If a person encounters any difficulties accessing the 2026 Annual Meeting during the check-in or meeting time, they can call the technical support number that will be provided on the 2026 Annual Meeting log-in page.
As always, whether or not a stockholder plans to attend the virt...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
